The overall rise in the risk of uterine cancer with tamoxifen use is lower (less than one%), and it goes again to normal in just a few years of stopping the drug.Now, about 11 million persons are living using a tumour which contains an inactivating mutation of TP53 (the human gene that encodes p53) and A different 11 million have tumours through wh